Compare Cassava Sciences Inc (FLNA) vs Direxion Daily TSLA Bull 2X Shares (TSLL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Direxion Daily TSLA Bull 2X Shares — how do they compare? Cassava Sciences Inc trades at $1.08 (market cap $53.14M), while Direxion Daily TSLA Bull 2X Shares trades at $11.79. The key difference: Direxion Daily TSLA Bull 2X Shares is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | TSLL | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $4.64 | $23.03 |
52-Week Low | $1.09 | $10.29 |
Enterprise Value | -$33.43M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
TSLL is trading at $11.879, down 3.81% on the day, with a bearish technical outlook indicated by moving averages. The stock shows oversold conditions on short-term RSI. Recent news highlights its connection to Tesla and leveraged-inverse ETF strategies. Key financial ratios are unavailable, limiting fundamental clarity.
The outlook is cautious due to technical weakness and lack of current financial data. Investment opportunity hinges on Tesla's performance and ETF demand, but risks include high volatility and dependency on underlying assets. Investors need updated fundamentals for a clear assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Direxion Daily TSLA Bull 2X Shares
TSLL provides 200% of the daily performance of Tesla, Inc. (TSLA). It uses swaps and financial derivatives to achieve its 2x leverage, making it a high-volatility tool for tactical trading rather than long-term investment due to daily resets.
Read more on TSLL →
